Dr.inmaculada Ibanez De Caceres
University Hospital La Paz
Inmaculada Ibanez de Caceres has completed her PhD from Complutense University of Madrid, Spain; 6 years of Post-doctoral studies from Fox Chase Cancer Center at Philadelphia, and IIB/CSIC, from the National Research Council, Spain. She coordinates the experimental therapies and biomarkers group at The Sanitary Research Institution IdiPAZ, and is the Director of the Cancer Epigenetics Group at University Hospital La Paz, Madrid. She has published more than 30 papers in reputed journals, is the main author of two patents based on biomarkers of clinical use, one of them already licensed and under exploitation, and has been serving as a Full Member representing her institution at the biomarkers platform form the European Infrastructure for Translational Medicine (EATRIS).